- Report
- September 2023
- 327 Pages
Global
From €3344EUR$3,600USD£2,797GBP
- Report
- September 2023
- 159 Pages
Asia Pacific
From €1393EUR$1,500USD£1,166GBP
- Report
- September 2023
- 153 Pages
Asia Pacific
From €1393EUR$1,500USD£1,166GBP
- Report
- July 2023
- 252 Pages
Global
From €3344EUR$3,600USD£2,797GBP
- Report
- April 2023
- 192 Pages
Global
From €3344EUR$3,600USD£2,797GBP
- Report
- March 2023
- 189 Pages
Global
From €3344EUR$3,600USD£2,797GBP
- Report
- March 2023
- 73 Pages
Africa, Middle East
From €1393EUR$1,500USD£1,166GBP
- Report
- September 2022
- 119 Pages
North America
From €1393EUR$1,500USD£1,166GBP
- Report
- August 2022
- 82 Pages
Europe
From €1393EUR$1,500USD£1,166GBP
- Report
- March 2026
- 234 Pages
Germany
From €4505EUR$4,850USD£3,769GBP
- Report
- March 2026
- 235 Pages
India
From €4505EUR$4,850USD£3,769GBP
- Report
- March 2026
- 233 Pages
Canada
From €4505EUR$4,850USD£3,769GBP
- Report
- March 2026
- 242 Pages
China
From €4505EUR$4,850USD£3,769GBP
- Report
- September 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 173 Pages
Canada
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 182 Pages
China
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 174 Pages
Germany
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 175 Pages
India
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 183 Pages
Canada
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 192 Pages
China
From €4505EUR$4,850USD£3,769GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more